TipRanks
Brii Biosciences Limited (DE:7SS)
FRANKFURT:7SS
Germany Market

Brii Biosciences Limited (7SS) Income Statement

2 Followers

Brii Biosciences Limited Income Statement

Last quarter (Q2 2026), Brii Biosciences Limited's total revenue was ¥0.00, a decrease of -100.00% from the same quarter last year. In Q2, Brii Biosciences Limited's net income was ¥-99.17M. See Brii Biosciences Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 18.12M¥ 54.29M¥ 56.32M¥ 51.63M¥ 92.54M
Gross Profit
¥ 0.00¥ 54.29M¥ 56.32M¥ 51.63M¥ 92.54M
Operating Expenses
¥ 310.26M¥ 453.79M¥ 600.62M¥ 565.81M¥ 703.02M
Depreciation and Amortization
¥ 5.59M¥ 6.99M¥ 15.67M¥ 7.94M¥ 7.68M
EBITDA
¥ -290.29M¥ -392.51M¥ -168.20M¥ -503.58M¥ -602.80M
Operating Income
¥ -295.88M¥ -399.50M¥ -544.30M¥ -513.85M¥ -610.48M
Other Income/Expenses
¥ 79.47M¥ -112.88M¥ 359.93M¥ 24.06M¥ -3.58B
Pretax Income
¥ -216.42M¥ -512.38M¥ -184.37M¥ -489.78M¥ -4.19B
Net Income
¥ -216.86M¥ -508.16M¥ -174.83M¥ -484.31M¥ -4.12B
Per Share Metrics
Basic EPS
¥ -0.30¥ -0.70¥ -0.24¥ -0.67¥ -9.48
Diluted EPS
¥ -0.30¥ -0.70¥ -0.24¥ -0.67¥ -9.48
Weighted Average Shares Outstanding
721.87M 730.25M 728.10M 723.48M 439.05M
Weighted Average Shares Outstanding (Diluted)
721.87M 730.25M 728.10M 723.48M 439.05M
Currency in CNY

Brii Biosciences Limited Earnings and Revenue History